The Anal Fistula drugs in development market research report provides comprehensive information on the therapeutics under development for Anal Fistula , complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses key aspects of the companies and drugs in development for Anal Fistula . Buy the report here.
Smarter leaders trust GlobalData
The report also covers the descriptive pharmacological action of the therapeutics and the latest news and press releases. Additionally, the report provides an overview of the key players involved in therapeutic development for Anal Fistula and features dormant and discontinued products.
GlobalData tracks seven drugs in development for Anal Fistula by seven companies/universities/institutes. The top development phase for Anal Fistula is phase ii with three drugs in that stage. The Anal Fistula pipeline has six drugs in development by companies and one by universities/ institutes. Some of the companies in the Anal Fistula pipeline products market are: Tehran University of Medical Sciences, Stempeutics Research and Takeda Pharmaceutical.
The key mechanisms of action in the Anal Fistula pipeline product include The Anal Fistula pipeline products include nine routes of administration with the top ROA being Parenteral and two key molecule types in the Anal Fistula pipeline products market including Cell Therapy, and Gene-Modified Cell Therapy.
Anal Fistula overview
An anal fistula is a small tunnel that develops under the skin that connects the anal canal in the colon to the skin of the buttocks. It is also called as fistula-in-ano.
For a complete picture of Anal Fistula ‘s pipeline drug market, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s pipeline drugs offers detailed profiles of pharmaceutical drugs in all stages of pre-clinical and clinical development, from discovery through to pre-registration. Coverage is limited to novel human medicinal drugs and biosimilars seeking market approval proprietary and is one of two primary repositories of pharmaceutical drug information offered by GlobalData through its Pharmaceutical Intelligence Center.
